Herbert M. Geller, Ph.D. - Developmental Neurobiology Section, National Heart Lung and Blood Institute, NIH, Bethesda, NH
There is very little recovery of function following traumatic injury to the mammalian CNS. In large part, this is due to the presence of molecules that actively inhibit axonal growth after injury, especially chondroitin sulfate proteoglycans (CSPGs). We will discuss the mechanisms of growth inhibition by CSPGs and strategies to overcome them to promote regeneration.
May 03, 2012 @ 4:00 p.m.
Medical Center | 3-6408 (K-307)